Mechanism and Intervention of Pyroptosis Involved in Reperfusion Injury in Acute Coronary Syndrome
DOI:
https://doi.org/10.53469/jcmp.2025.07(03).40Keywords:
Acute coronary syndrome, Myocardial ischemia-reperfusion injury, Pyroptosis, Pathway mechanisms, ReviewAbstract
Opening occluded blood vessels to achieve myocardial reperfusion is the most critical treatment for acute coronary syndromes, but with the return of blood, the heart tissue produces a strong stress response, and the infarction may be expanded or the heart function may be reimpaired, which is called myocardial ischemia reperfusion injury (MIRI). As a programmed cell death mode, pyroptosis has been widely confirmed to be involved in the MIRI process, and the main morphological characteristics are the formation of cell membrane pores of about 10~20nm, cell swelling accompanied by plasma membrane rupture, and the release of cell contents. In this article, we will review the mechanism of pyroptosis in MIRI and the intervention of various drugs in the pyroptosis pathway, so as to provide new ideas for exploring and improving MIRI.
References
Wu J, Shyy M, Shyy J Y, et al. Role of inflammasomes in endothelial dysfunction[J]. Br J Pharmacol, 2024.
Zhang H, Hu H, Zhai C, et al. Cardioprotective Strategies After Ischemia-Reperfusion Injury[J]. Am J Cardiovasc Drugs, 2024,24(1):5-18.
Wang Shuhui. Role and mechanism of GSK-3β activation of NLRP3 inflammatory vesicles aggravating myocardial infarction [D]. Zhengzhou University, 2021.
Zhaolin Z, Guohua L, Shiyuan W, et al. Role of pyroptosis in cardiovascular disease[J]. Cell Prolif, 2019, 52(2): e12563.
Shi H, Gao Y, Dong Z, et al. GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury[J]. Circ Res, 2021,129(3):383-396.
Yanpiset P, Maneechote C, Sriwichaiin S, et al. Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies[J]. Acta Pharm Sin B, 2023,13(1):29-53.
Kovacs S B, Miao E A. Gasdermins: Effectors of Pyroptosis[J]. Trends Cell Biol, 2017,27(9):673-684.
Xu Z, Chen Z, Wu X, et al. Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation[J]. Front Immunol, 2020, 11: 609441.
Katsnelson M A, Rucker L G, Russo H M, et al. K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling[J]. J Immunol, 2015, 194(8):3937-3952.
Theofilis P, Sagris M, Oikonomou E, et al. Inflammatory Mechanisms Contributing to Endothelial Dysfunction[J]. Biomedicines, 2021,9(7).
Taabazuing C Y, Okondo M C, Bachovchin D A. Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages [J]. Cell Chem Biol, 2017,24(4):507-514.
Liu Y, Li X, Sun T, et al. Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications[J]. Eur J Pharmacol, 2024,971:176464.
Takahashi M. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction[J]. J Cardiovasc Pharmacol, 2019,74(3):188-193.
Xing Y, Sui Z, Liu Y, et al. Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy[J]. Basic Res Cardiol, 2022,117(1):20.
Wang B, Wang Y, Zhang J, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis[J]. Arch Toxicol, 2023,97(6):1439-1451.
Chen C, Zhang L, Jin Z, et al. Mitochondrial redox regulation and myocardial ischemia-reperfusion injury [J]. Am J Physiol Cell Physiol, 2022, 322(1): C12-C23.
Mastrocola R, Penna C, Tullio F, et al. Pharmacological Inhibition of NLRP3 Inflammasome Attenuates Myocardial Ischemia/Reperfusion Injury by Activation of RISK and Mitochondrial Pathways[J]. Oxid Med Cell Longev, 2016,2016:5271251.
Chen X, Lin S, Dai S, et al. Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury[J]. Inflamm Res, 2022, 71(2):227-241.
Wang Q, Wu J, Zeng Y, et al. Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease[J]. Clin Chim Acta, 2020,510:62-72.
Wang W, Wu Q, Sui Y, et al. Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome[J]. Biomed Pharmacother, 2017, 86:32-40.
Li H, Yang D, Zhang Y, et al. Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury[J]. Chin Med, 2022, 17(1):73.
Xu M, Li X, Song L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/ reperfusion injury via inhibiting JAK/STAT pathway[J]. Pharm Biol, 2020,58(1):655-663.
Mahdiani S, Omidkhoda N, Rezaee R, et al. Induction of JAK2/STAT3 pathway contributes to protective effects of different therapeutics against myocardial ischemia/ reperfusion [J]. Biomed Pharmacother, 2022, 155: 113751.
Zhong Y, Yin B, Ye Y, et al. The bidirectional role of the JAK2/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury[J]. Exp Neurol, 2021,341:113690.
Yao M, Wang Z, Jiang L, et al. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway[J]. Biomed Pharmacother, 2022, 153: 113498.
Liu G, Zhang B, Hu Q, et al. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3beta signaling pathway[J]. Biochem Biophys Res Commun, 2020,531(2):242-249.
Pan S, Wang F, Hui Y, et al. Insulin reduces pyroptosis- induced inflammation by PDHA1 dephosphorylation- mediated NLRP3 activation during myocardial ischemia- reperfusion injury[J]. Perfusion, 2023, 38(6): 1277-1287.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rong Liu, Zhiyang Sang, Le Shen
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
